| |
Microbial skin sealant group
(n = 159) |
Control group
(n=132) |
p-value |
| Age (years), mean ± SD |
68.3 ± 7.7 |
69.0 ± 8.6 |
0.465 |
| Gender |
|
|
|
| Male |
107 (67.3) |
88 (66.7) |
|
|
Female |
52 (32.7) |
44 (33.3) |
|
| Hyperlipidaemia |
129 (81.1) |
117 (88.6) |
0.078 |
| Arterial hypertension |
157 (98.7) |
131 (99.2) |
0.674 |
| COPD |
28 (17.6) |
34 (25.8) |
0.091 |
| Diabetes mellitus |
70 (44.0) |
43 (32.6) |
0.046 |
| Peripheral artery disease |
40 (25.2) |
33 (25.0) |
1.000 |
| Carotid artery disease |
31 (19.5) |
13 (9.8) |
0.022 |
| Cardiovascular accident |
22 (13.8) |
15 (11.4) |
0.528 |
| Renal failure |
37 (23.3) |
35 (26.5) |
0.523 |
| LV ejection fraction, mean ± |
42.4 ± 14.8 |
42.3 ± 14.3 |
0.954 |
| SD |
|
|
|
| Congestive heart failure |
71 (44.7) |
49 (37.1) |
0.194 |
| Acute myocardial infarction |
69 (43.4) |
55 (41.7) |
0.766 |
| Priority of procedure |
|
|
|
| Elective |
101 (63.5) |
85 (64.4) |
0.877 |
| Urgent/emergency |
58 (36.5) |
47 (35.6) |
|
| Perfusion time |
|
|
|
| <100 min |
95 (59.7) |
75 (56.8) |
0.614 |
|
≥ 100 min |
64 (40.3) |
57 (43.2) |
|
COPD, chronic obstructive pulmonary disease; LV, left ventricular; SD, standard
deviation |
